Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neoadjuvant Stereotactic Radiation Therapy for Resectable Brain Metastases

NCT04069910 is registered in ClinicalTrials.gov with Jonsson Comprehensive Cancer Center as lead sponsor.

NCT NCT04069910
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04069910 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neoadjuvant Stereotactic Radiation Therapy for Resectable Brain Metastases
Lead sponsor
Jonsson Comprehensive Cancer Center
Phase
Not applicable
Overall status
Withdrawn
Start date
August 26, 2019
Completion date
November 30, 2020
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor, malignant neoplasm, brain